The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells.
Leukemia
; 30(9): 1963, 2016 09.
Article
in En
| MEDLINE
| ID: mdl-27600169
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Leukemia
Year:
2016
Document type:
Article